Senior Scientist (Neuropsychiatry)

Employer: Transcend Therapeutics
Date Posted: Oct 25, 2021
Employment: Full Time
Focus / Industry:
Signup or Login to apply for this job & others in the psychedelic industry

About Transcend Therapeutics:

Transcend Therapeutics discovers, develops, and delivers next-generation psychedelic therapies to work toward a world in which people no longer suffer from neuropsychiatric disease. Transcend focuses on developing medicines that are accessible to a larger percentage of patients in need, specifically the tens of millions of patients who already take psychotropic medication. We have already advanced two lead compounds for PTSD, depression, and fibromyalgia, and plan to begin first-in-patient phase II trials in the first half of 2022. Our lead product has already demonstrated >85% real-world response rates in patients with treatment-resistant PTSD and depression.

Transcend’s leadership team includes the first scientist to receive federal funding for clinical psychedelic research in 54 years and a drug development executive with pivotal contributions to 9 FDA approvals and five major biopharma exits totalling $3.5 billion in combined value. We are backed by AlleyCorp, an incubator and venture capital fund that has founded some of the most transformative companies in New York, including MongoDB, Business Insider, Gilt Groupe, Zola, Nomad Health, and many others. AlleyCorp incubations have collectively raised $1B+ in venture capital with an aggregate value of $30B+.

As a Public Benefit Corporation, we have pledged 10% of the founding shares toward nonprofits focused on scientific research and patient access.

About the role:

The primary responsibility of the Scientist is to design, outsource, and deliver in vitro and in vivo studies to support preclinical development at Transcend Therapeutics. This position reports directly to the Chief Development Officer.

Key responsibilities of the role will include:

  • Design and delivery of in vitro and in vivo target engagement, pharmacodynamics, and disease-relevant behavioral models relevant to psychiatric diseases
  • Critically analyze and interpret complex data sets, utilizing appropriate statistics.
  • Define realistic timelines for studies and meet delivery deadlines
  • Manage external vendors (contracts, SOWs etc) to ensure high quality deliverables and adherence to planned timelines/budgets
  • Supporting Chief Development Officer with authorship of reports for inclusion in regulatory documents (e.g., Investigator’s Brochure, IND Application, etc.)
  • Ability to rapidly acquire additional necessary skills, as needed

This is a great opportunity to step into a high-impact, high-mentorship role on the early team of Transcend Therapeutics. The previous scientist mentored by the Chief Development Officer is now the Chief Technology Officer of a public biotech company.  We offer competitive cash and equity compensation; medical, dental, and vision insurance; unlimited vacation and sick time; and more.

Who you are/what you bring:

  • Mission-driven and passionate about reducing the burden of psychiatric and neurological illness
  • Ph.D. in neuroscience or physiology (or related degree)  with 2-3 years of relevant pharmaceutical industry experience. Exceptional academic candidates will also be considered
  • Expertise and publications relevant to translational science in PTSD, depression, or fibromyalgia preferred
  • Familiarity with mechanisms and genetics underlying neuropsychiatric illness
  • Ability to establish, maintain, and manage effective collaborations with external partners
  • Excellent communication skills at both detailed and summarized levels
  • Team player with ability to conduct independent research
  • Ability to quickly prioritize deliverables according to team and business requirements

We are committed to building a diverse, inclusive and talented team, free from discrimination. If you're excited about our mission but don't meet 100% of the qualifications above, we encourage you to apply.

Interested in this job?
Gain access to the psychedelic industry’s most robust platform for free.
Last updated: Nov 18, 2023